Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Reexamination Certificate
2005-05-03
2005-05-03
Salimi, Ali R. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
C530S300000, C536S023720
Reexamination Certificate
active
06887478
ABSTRACT:
Recombinantly produced L1 major capsid proteins which mimic conformational naturalizing epitopes on human and animal papilloma virions including canine and equine papilloma virions are provided. These recombinant proteins are useful as vaccines for conferring protection against papillomavirus infection. Antibodies to the recombinant protein are also provided. Such antibodies are useful in the diagnosis and treatment of viral infection.
REFERENCES:
Jarrett, et al., Veterinary Record, 1990, pp. 473-475.
Fife, K., Australasian Journal of Dermatology, 1998, vol. 39, Suppl. 1S8-10.
Murphy, et al., Fields Virology, 1990 2ndEd., Chapter 19, pp. 480-482, only.
Ghim Shin-je
Jenson A. Bennett
Schlegel C. Richard
Georgetown University
Pillsbury & Winthrop LLP
Salimi Ali R.
LandOfFree
Formalin-treated human papillomavirus L1 protein vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formalin-treated human papillomavirus L1 protein vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formalin-treated human papillomavirus L1 protein vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3393970